Uncategorized
VIDEO: Omidria reduces use of pupil-dilating devices, surgery time
WASHINGTON ― At the American Society of Cataract and Refractive Surgery meeting here, Cynthia A. Matossian, MD, discusses a study on the use of Omidria (phenylephrine 1% and ketorolac 0.3% intraocular solution, Omeros) in cataract surgery. The study found that intraoperative use of Omidria reduces the use of pupil-dilating devices by 67% and reduces the overall length of cataract surgery.